Biofrontera (BFRI) Enterprise Value (2020 - 2025)
Biofrontera's (BFRI) quarterly Enterprise Value came in at -$6.4 million in Q4 2025, down 8.41% year-on-year from -$7.0 million in Q4 2024, and down 87.01% quarter-over-quarter from -$3.4 million in Q3 2025.
Biofrontera (BFRI) Enterprise Value (2020 - 2025) Analysis & Trends
Biofrontera's Enterprise Value history runs 6 years deep, the most recent figure standing at -$6.4 million for Q4 2025.
- On a quarterly basis, Enterprise Value fell 8.41% year-over-year to -$6.4 million in Q4 2025; TTM through Dec 2025 was -$6.4 million, a 8.41% decrease from a year earlier, with the FY2025 full-year figure at -$6.4 million, down 8.41% from the prior year.
- Enterprise Value declined to -$6.4 million in Q4 2025 per BFRI's latest filing, from -$3.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.4 million in Q4 2023 and bottomed at -$31.9 million in Q2 2022.
- The 5-year median for Enterprise Value is -$6.4 million (2025), against an average of -$11.1 million.
- Across the five-year window, Enterprise Value slumped 1502.56% in 2022 and surged 94.88% in 2023, its largest moves.
- Year by year, Enterprise Value stood at -$24.5 million in 2021, then fell by 13.29% to -$27.8 million in 2022, then jumped by 94.88% to -$1.4 million in 2023, then plunged by 316.05% to -$5.9 million in 2024, then dropped by 8.41% to -$6.4 million in 2025.
- Per Business Quant, the three latest BFRI Enterprise Value figures stand at -$6.4 million (Q4 2025), -$3.4 million (Q3 2025), and -$7.2 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | -6.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.41 Mn |
| Sep 30, 2025 | -3.43 Mn |
| Jun 30, 2025 | -7.21 Mn |
| Mar 31, 2025 | -1.81 Mn |
| Dec 31, 2024 | -5.91 Mn |
| Sep 30, 2024 | -2.88 Mn |
| Jun 30, 2024 | -4.39 Mn |
| Mar 31, 2024 | -3.84 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Sep 30, 2023 | -6.72 Mn |
| Mar 31, 2023 | -8.90 Mn |
| Dec 31, 2022 | -27.76 Mn |
| Sep 30, 2022 | -27.50 Mn |
| Jun 30, 2022 | -31.91 Mn |
| Mar 31, 2022 | -22.40 Mn |
| Dec 31, 2021 | -24.50 Mn |
| Sep 30, 2021 | -1.72 Mn |
| Dec 31, 2020 | -8.10 Mn |